Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Size matters?

Size matters? There is also Allergan's traditional strength in aesthetics, most notably Botox (a pharma product whose place in the popular imagination is perhaps the closest to Pfizer's own Viagra), though

Pfizer to form specialty drugs unit after Allergan takeover

Pfizer to form specialty drugs unit after Allergan takeover brands, which include wrinkle treatment Botox.

Allergan/Pfizer takeover talks confirmed

Allergan/Pfizer takeover talks confirmed Confirmation of the discussions has heightened debate about how much Pfizer may be prepared to pay to get hold of Allergan and profitable products such as wrinkle treatment Botox.

Ashfield UK makes two new business development appointments

Ashfield UK makes two new business development appointments He also successfully launched and managed a direct competitor to Botox having joined the business at the beginning of September.

Teva buys Allergan generics unit for $40.5bn

Teva buys Allergan generics unit for $40.5bn Will now drop its six-month pursuit of Mylan.  . The world's largest generic drug manufacturer Teva has bought Botox-maker Allgeran's copycat medicines unit for more than $40bn. ... Allergan will as a result own around 10% of Teva, while in return the

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...

Infographics